Vinzenz Fleischer
Vinzenz Fleischer
Medical Center of the Johannes-Gutenberg University of Mainz
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Graph theoretical framework of brain networks in multiple sclerosis: a review of concepts
V Fleischer, A Radetz, D Ciolac, M Muthuraman, G Gonzalez-Escamilla, ...
Neuroscience 403, 35-53, 2019
Structural correlates for fatigue in early relapsing remitting multiple sclerosis
J Wilting, HO Rolfsnes, H Zimmermann, M Behrens, V Fleischer, F Zipp, ...
European radiology 26 (2), 515-523, 2016
Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis
V Fleischer, A Gröger, N Koirala, A Droby, M Muthuraman, P Kolber, ...
Multiple Sclerosis Journal 23 (3), 432-441, 2017
Structural brain network characteristics can differentiate CIS from early RRMS
M Muthuraman, V Fleischer, P Kolber, F Luessi, F Zipp, S Groppa
Frontiers in neuroscience 10, 14, 2016
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
A Stroet, C Hemmelmann, M Starck, U Zettl, J Dörr, F Paul, ...
Therapeutic advances in neurological disorders 5 (2), 75-79, 2012
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
V Fleischer, M Friedrich, A Rezk, U Bühler, E Witsch, T Uphaus, S Bittner, ...
Multiple Sclerosis Journal 24 (5), 632-641, 2018
Power estimation for non-standardized multisite studies
A Keshavan, F Paul, MK Beyer, AH Zhu, N Papinutto, RT Shinohara, ...
NeuroImage 134, 281-294, 2016
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study
A Droby, KSL Yuen, M Muthuraman, SC Reitz, V Fleischer, J Klein, ...
Brain imaging and behavior 10 (4), 1117-1126, 2016
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex
RM Gracien, SC Reitz, SM Hof, V Fleischer, H Zimmermann, A Droby, ...
European radiology 26 (8), 2578-2586, 2016
Multimodal quantitative MRI assessment of cortical damage in relapsing‐remitting multiple sclerosis
RM Gracien, A Jurcoane, M Wagner, SC Reitz, C Mayer, S Volz, SM Hof, ...
Journal of Magnetic Resonance Imaging 44 (6), 1600-1607, 2016
Quantitative T1 and proton density mapping with direct calculation of radiofrequency coil transmit and receive profiles from two‐point variable flip angle data
S Baudrexel, SC Reitz, S Hof, RM Gracien, V Fleischer, H Zimmermann, ...
NMR in Biomedicine 29 (3), 349-360, 2016
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients
A Droby, V Fleischer, M Carnini, H Zimmermann, V Siffrin, J Gawehn, ...
NeuroImage: Clinical 8, 110-116, 2015
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis
P Kolber, S Montag, V Fleischer, F Luessi, J Wilting, J Gawehn, A Gröger, ...
Journal of neurology 262 (6), 1473-1482, 2015
Cardiotoxicity of mitoxantrone treatment in a German cohort of 639 multiple sclerosis patients
V Fleischer, A Salmen, S Kollar, V Weyer, V Siffrin, A Chan, F Zipp, ...
Journal of Clinical Neurology 10 (4), 289-295, 2014
Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry
RM Gracien, SC Reitz, SM Hof, V Fleischer, H Zimmermann, A Droby, ...
NMR in Biomedicine 29 (4), 444-450, 2016
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2
SC Reitz, SM Hof, V Fleischer, A Brodski, A Gröger, RM Gracien, A Droby, ...
Brain imaging and behavior 11 (3), 744-753, 2017
Metabolic patterns in chronic multiple sclerosis lesions and normal-appearing white matter: intraindividual comparison by using 2D MR spectroscopic imaging
V Fleischer, R Kolb, S Groppa, F Zipp, U Klose, A Gröger
Radiology 281 (2), 536-543, 2016
Frontal lobe connectivity and network community characteristics are associated with the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease
N Koirala, V Fleischer, M Glaser, KE Zeuner, G Deuschl, J Volkmann, ...
Brain topography 31 (2), 311-321, 2018
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis
S Grey, A Salmen, N von Ahsen, M Starck, A Winkelmann, UK Zettl, ...
Journal of neuroimmunology 278, 277-279, 2015
Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression
A Nemecek, H Zimmermann, J Rübenthaler, V Fleischer, M Paterka, ...
Multiple Sclerosis Journal 22 (4), 483-493, 2016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20